05:17 PM EST, 03/05/2024 (MT Newswires) -- DexCom ( DXCM ) said Tuesday its prescription-free glucose biosensor, Stelo by Dexcom ( DXCM ), won clearance from the US Food and Drug Administration.

Stelo, designed for individuals aged 18 and above who don't use insulin therapy, is a small, wearable sensor placed on the back of the upper arm to prove real-time glucose information directly to the user's smartphone, DexCom ( DXCM ) said.

Stelo will be available to purchase online in the summer, DexCom ( DXCM ) said.

Price: 123.72, Change: +1.94, Percent Change: +1.59